Quality of life in climacteric Chilean women treated with low-dose estrogen

Maturitas

Volumn 61, Issue 3, 2008, Pages 248-251

  Aedo, Sócrates ^a   Schiattino, Irene ^a   Cavada, Gabriel ^a   Porcile, Arnaldo ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Climacteric; Estrogen in low doses; HRQoL; HT; Quality of life

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; CHILE; FEMALE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; QUALITY OF LIFE;

CHILE; CROSS-SECTIONAL STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC;

EID: 56949106341     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.07.013     Document Type: Article

References (33)

1. Utian W.H. The normal menopause transition ovarian function, therapy oriented definition of menopause and climacteric. Exp Gerontol 29 3-4 (1994) 245-251
2. Mc Kinlay S.M. The normal menopause transition overview. Maturitas 2 (1996) 137-145
3. Heinemann K., Ruebig A., Potthoff P., et al. The Menopause Rating Scale [MRS] scale: a methodological review. Health Qual Life Outcomes 2 (2004) 45-52
4. Palacios S., Ferrer-Barriendo J., Parrillac J.J., et al. Calidad de vida relacionada con la salud en la mujer española durante la perimenopausia y posmenopausia. Desarrollo y validación de la Escala Cervantes. Med Clin [Barc] 122 6 (2004) 205-211
5. Blumel J.E., Castelo-Branco C., Binfa L., et al. Quality of life after the menopause: a population study. Maturitas 34 1 (2000) 17-23
6. Blumel J.E., Castelo-Branco C., Cancelo M.J., et al. Relationship between psychological complaints and vasomotor symptoms during climacteric. Maturitas 49 3 (2004) 205-210
7. Porcile A., Gallardo E., Onetto P., and Schächter D. Very low estrogen-desogestrel contraceptive in perimenopausal hormonal replacement. Maturitas 18 2 (1994) 77-160
8. Porcile A., Martínez E., and Venegas E. Esquema terapéutico con etinil estradiol y medroxiprogesterona acetato en el climaterio. Rev Chil Obstet Ginecol 52 2 (1987) 107-113
9. Utian W.H., Shoupe D., Bachmann G., Pinkerton J.V., and Pickar J.H. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Women's Health, Osteoporosis, Progestin, Estrogen Study [HOPE]. Fertil Steril 75 6 (2001) 1065-1079
10. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study [HERS] Research Group. JAMA 280 (1998) 605-613
11. Grady D., Herrington D., Bittner V., et al. HERS Research Group Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up [HERS II]. JAMA 288 (2002) 49-57
12. Rossouw J.E., Anderson G.L., Prentice R.L., et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
13. Ross R.K., Paganini-Hill A., Wan P.C., and Pike M.C. Effect of hormone replacement therapy on breast cancer: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92 (2000) 328-332
14. Schairer C., Lubin J., Troisi R., Sturgeon S., Brinton L.A., and Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 283 (2000) 485-491
15. Porcile A., Aedo S., and Hernández Y. Fundamentos del uso de estrógenos en dosis bajas con progestina periódica en TRH oral para mujeres postmenopáusicas. Rev Chil Obstet Ginecol 68 5 (2003) 430-438
16. Kuhl H. Pharmacokinetics of oestrogens and progestogens. Maturitas 12 (1990) 171-190
17. Grow D. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin N Am 29 (2002) 425-436
18. Rebar R.W., Trabal J., and Mortola J. Low-dose esterified estrogens [0.3 mg/day]: long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric 3 3 (2000) 176-182
19. Gambacciani M., Ciaponi M., Cappagli B., et al. Effects low-dose continuos conbined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 44 (2003) 157-163
20. Haines C.J., Yim S.F., Chung T.K.H., et al. A propective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 44 (2003) 207-214
21. Ray W.A., Griffin M.R., and Avorn J. Evaluating drugs after approval for clinical use. N Engl J Med 329 (1993) 2029-2032
22. Badía X., and Tudela L. Reflexiones sobre la investigación de resultados en salud. Aten Primaria 30 6 (2002) 388-391
23. Aedo S., Porcile A., and Irribarra C. Calidad de vida relacionada con el climaterio en una población chilena de mujeres saludables. Rev Chil de Obstet y Ginecol 71 6 (2006) 402-409
24. Heinemann L.A.J., Dominh T., Strelow F., Gerbsch S., Schnitker J., and Schneider H.P.G. The menopause rating scale [MRS] as outcome measure for hormone treatment? A validation study. Health Qual Life Outcomes 2 (2004) 67-73
25. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis Diabetes Mellitus. Diabetes Care 26 Suppl 1 (2003) 3160-3167
26. Daniel W. Distribución Ji-cuadrada y análisis de frecuencias. En su: Bioestadística base para el análisis de las ciencias de la salud. Cuarta ed. México, Limusa; 2004. p. 571-657.
27. Daniel W. Estadística no paramétrica y de libre distribución. En su: Bioestadistica base para el análisis de las ciencias de la salud. Cuarta ed. México, Limusa; 2004. p. 657-736.
28. Potthoff P., Heinemann L.A.J., Schneider H.P.G., Rosemeier H.P., and Hauser G.A. Menopause-Rating Skala [MRS]: Methodische Standardisierung in der deutschen Bevölkerung. Zentralbl Gynakol 122 (2000) 280-286
29. Heinemann K., Assmann A., Möhner S., Schneider H.P.G., and Heinemann L.A.J. Reliabilität der Menopause-Rating-Skala [MRS]. Untersuchung für die Deutsche Bevölkerung. Zentralbl Gynakol 124 (2002) 161-163
30. Schneider H.P.G., Heinemann L.A.J., Rosemeier H.P., Potthoff P., and Behre H.M. The Menopause Rating Scale [MRS]: reliability of scores of menopausal complaints. Climacteric 3 (2000) 59-64
31. Schneider H.P.G., Heinemann L.A.J., Rosemeier H.P., Potthoff P., and Behre H.M. The Menopause Rating Scale [MRS]: comparison with Kupperman Index and quality of life scale SF-36. Climacteric 3 (2000) 50-58
32. ®. Maturitas 37 (2000) 113-124
33. Heinemann L.A.J., Potthoff P., and Schneider H.P.G. International versions of the Menopause Rating Scale [MRS]. Health Qual Life Outcomes 1 (2003) 28